Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | AHR | P35869 | 2/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 5/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.55 |
| ▸ | HTR2C | P28335 | 3/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.55 |
| ▸ | HTR1D | P28221 | 2/20 | 0.55 |
| ▸ | HTR1B | P28222 | 2/20 | 0.55 |
| ▸ | HTR7 | P34969 | 2/20 | 0.55 |
| ▸ | HTR6 | P50406 | 2/20 | 0.55 |
| ▸ | MPO | P05164 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | CTSK | P43235 | 1/20 | 0.55 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29376106 | 1.00 | MEN1 (0.62) | MEN1KMT2ACYP3A4MAPTAHR | |
| SCHEMBL6580411 | 0.98 | MEN1 (0.60) | MEN1KMT2ACYP3A4MAPTAHR | |
| SCHEMBL6580417 | 0.98 | MEN1 (0.60) | MEN1KMT2ACYP3A4MAPTAHR | |
| Sulfurous Acid SCHEMBL30338559 | 0.92 | MAPT (0.53) | MEN1KMT2ACYP3A4MAPTAHR | |
| Sulfurous Acid SCHEMBL27843073 | 0.90 | MEN1 (0.51) | MEN1KMT2ACYP3A4MAPTAHR | |
| Indole-3-Acetic Acid SCHEMBL30486253 | 0.87 | MAPT (0.61) | MEN1KMT2ACYP3A4MAPTAHR | |
| Sulfurous Acid SCHEMBL468351 | 0.87 | MAPT (0.50) | MEN1KMT2ACYP3A4MAPTAHR | |
| Tert-Butyl Formate SCHEMBL27652098 | 0.86 | MEN1 (0.47) | MEN1KMT2ACYP3A4MAPTAHR | |
| SCHEMBL4620881 | 0.85 | MAPT (0.81) | MEN1KMT2ACYP3A4MAPTAHR | |
| SCHEMBL10382799 | 0.84 | MEN1 (0.67) | MEN1KMT2ACYP3A4MAPTAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4739326-A2 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR Biome ApS (DK) | 2026-05-13 | — | — | EP | claimed |
| WO-2026087508-A1 | HYDROGELS CONTAINING COVALENTLY LINKED COFACTORS AND METHODS FOR PREPARING THE SAME | HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) | 2026-04-30 | — | — | WO | claimed |
| US-20260115234-A1 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR BIOME APS (DK) | 2026-04-30 | — | — | US | claimed |
| US-20260068891-A1 | FUNGAL SPECIES, COMPOSITIONS DERIVED THEREFROM, AND USES THEREOF | HARVARD COLLEGE (US) | 2026-03-12 | — | — | US | claimed |
| EP-4698567-A1 | HYDROGELS CONTAINING COVALENTLY LINKED COFACTORS AND METHODS FOR PREPARING THE SAME | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2026-02-25 | — | — | EP | claimed |
| US-20250324977-A1 | ENGINEERED BACTERIA FOR ENHANCED CROP PRODUCTION | UNIV CALIFORNIA (US) | 2025-10-23 | — | — | US | claimed |
| US-20250246314-A1 | METHODS FOR THE DETECTION AND TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2025-07-31 | — | — | US | claimed |
| US-12331020-B2 | Method of synthesizing indole compounds | 1280225 B.C. LTD. (CA) | 2025-06-17 | — | — | US | claimed |
| CN-118782152-B | Organic heterocyclic biomarker for wild and cultivated four-large family fish population and application thereof | 中国水产科学研究院长江水产研究所 | 2025-05-20 | — | — | CN | claimed |
| US-20010046509-A1 | Use of cinnamic acid or of its derivatives in a cosmetic firming composition | BRETON LIONEL (FR) | 2001-11-29 | — | — | US | claimed |
| US-6267971-B1 | APPLYING COSMETIC COMPRISING CINNAMIC ACID OR DERIVATIVE FOR REDUCING SIGNS OF SKIN AGING | SOCIETE L'OREAL S.A. (FR) | 2001-07-31 | — | — | US | claimed |
| US-6264962-B1 | STIMULATION OF SKIN LIPID SYNTHESIS; MOISTURIZATION | SOCIETE L'OREAL S.A. (FR) | 2001-07-24 | — | — | US | claimed |
| WO-2000061587-A1 | PYRIDO-THIENO-DIAZEPINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID PYRIDO-THIENO-DIAZEPINES | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000055125-A2 | N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | claimed |
| US-6054137-A | A THERAPEUTIC TREATMENT FOR STIMULATING PROLIFERATION OF HUMAN KERATINOCYTES AND FOR SKIN DISORDERS | SOCIETE L'OREAL S.A. (FR) | 2000-04-25 | — | — | US | claimed |
| EP-0834558-A2 | Indoleacetaldehyde oxidase gene derived from plant and utilization thereof | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1998-04-08 | — | — | EP | claimed |
| EP-0445658-B1 | Indoleacetic acid synthetase encoding gene | MEIJI SEIKA KAISHA (JP) | 1998-02-04 | — | — | EP | claimed |
| US-5336766-A | Indoleacetic acid synthetase-encoding gene | MEIJI SEIKA KAISHA, LTD. (JP) | 1994-08-09 | — | — | US | claimed |
| EP-0445658-A1 | Indoleacetic acid synthetase encoding gene | MEIJI SEIKA KAISHA LTD. (JP) | 1991-09-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115234-A1 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | AADAT, NAT1, IDO1 | MEN1 3314/4885KMT2A 1796/4885CYP3A4 2727/4885 |
| US-20260068891-A1 | FUNGAL SPECIES, COMPOSITIONS DERIVED THEREFROM, AND USES THEREOF | UNG, TPSD1, TDO2 | MEN1 4487/4885KMT2A 3537/4885CYP3A4 448/4885 |
| US-12331020-B2 | Method of synthesizing indole compounds | IDO1, TPH1, TPH2 | MEN1 990/4885KMT2A 1937/4885CYP3A4 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.